DGAP-News: Fighting cervical cancer: Eckert&Ziegler wins World Bank tender to provide equipment for cancer clinics in Bangladesh
(firmenpresse) - DGAP-News: Eckert&Ziegler Strahlen- und Medizintechnik AG / Key
word(s): Incoming Orders/Tender Offer
Fighting cervical cancer: Eckert&Ziegler wins World Bank tender to
provide equipment for cancer clinics in Bangladesh
04.11.2013 / 07:45
---------------------------------------------------------------------
Berlin, November 4, 2013. Eckert&Ziegler Strahlen- und Medizintechnik has
won a tender in Bangladesh through its subsidiary Eckert&Ziegler BEBIG to
equip Bangladeshi cancer clinics with modern cancer irradiation equipment.
The devices from the MultiSource(R) series worth EUR3.1 million will
provide clinics with a full range of options for efficiently treating
gynecological tumors, with a focus on healing cervical cancer, across the
whole of East Bengal. Bangladesh has one of the world's highest mortality
rates from this type of malignant tumor. There are still few hospitals
where women with cancer can be effectively treated.
'We are particularly proud of this order,' said Abel Luzuriaga, Member of
the Executive Board and responsible for the medical device division at
Eckert&Ziegler. 'We have provided the first clinics in Bangladesh with
equipment several years ago and have now received a subsequent order for
deliveries on a large scale. Even if the order volume doesn't seem all that
large at first, the devices will make a significant difference to the lives
of tens of thousands of women - and their children. Cervical cancer often
occurs at a relatively young age and in many cases affects mothers.'
The MultiSource(R) line of cancer irradiation equipment with integrated
planning software became the most opted equipment and was chosen on account
of its long use of miniaturized cobalt-60 technology, which is unrivaled in
the market. They offer a high degree of flexibility and versatility and a
cost-effective solution for treating cancer. The devices operate at about a
sixth of the cost of conventional systems.
'We are pleased to see that emerging countries in Asia, Africa and South
America are increasingly gaining access to the latest medical
infrastructure that has long been available in other parts of the world. Of
course, these countries have to think twice before they invest. Our range
of MultiSource(R) devices is exactly what decision-makers are looking for,'
Luzuriaga added, 'which is clearly the reason they have ordered more.'
In the last few years, Eckert&Ziegler has already equipped more than 250
cancer clinics with these systems, and even nationwide in some countries.
The equipment is scheduled for delivery to Bangladesh Government radiation
clinics between December 2013 and March 2014.
The order is being funded by a consortium that includes the World Bank, the
World Health Organization, the EU and the KfW Development Bank as part of
the Health, Population&Nutrition Sector Development Program. The goal of
the five-year program is to guarantee basic health care for the treatment
of new cancer cases, which are on the rise in Bangladesh.
With around 670 employees, the Eckert&Ziegler Group (ISIN DE0005659700)
is one of the world's largest providers of isotope components for radiation
therapy and nuclear medicine. Besides irradiation equipment for
gynecological cancers, Eckert&Ziegler manufactures special products for
the treatment of prostate cancer and ocular tumors.
If you have any questions, please contact:
Eckert&Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 94 10 84-138
karolin.riehle(at)ezag.de
www.ezag.de
End of Corporate News
---------------------------------------------------------------------
04.11.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Eckert&Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: 49 30 941084-138
Fax: 49 30 941084-112
E-mail: karolin.riehle(at)ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart;
Freiverkehr in Berlin, Düsseldorf, Hamburg, München
End of News DGAP News-Service
---------------------------------------------------------------------
237466 04.11.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 04.11.2013 - 07:45 Uhr
Sprache: Deutsch
News-ID 312040
Anzahl Zeichen: 4371
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 374 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Fighting cervical cancer: Eckert&Ziegler wins World Bank tender to provide equipment for cancer clinics in Bangladesh"
steht unter der journalistisch-redaktionellen Verantwortung von
Eckert&Ziegler Strahlen- und Medizintechnik AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
